Category: Health & Medicines > Medicines
Country/Region: China State/Province: Jiangsu
Main Products: Coenzyme Q0, Ceftiofur Sodium, Ceftiofur HCL, Lumefantrine, Vinblastine Sulfate, Vinorelbine Bitartrate, Bicalutamide, Amfebutamone HCL, Clarithromycin
Business Type: Manufacturer, Retailer
Year Established: 2006
Employees: Above 1000 People
Plant Area: 10,000-30,000 square meters
Fax: 86-0576-88822496
Main Markets: South America 9% Africa 12% Eastern Asia 10% Domestic Market 8% North America 10% Eastern Europe 12% Southern Europe 10% Mid East 12% Northern Europe 12% Oceania 5%
Trade Capacity: FOB, EXW, DDU
Contract Manufacturing: OEM Service Offered,Buyer Label Offered
Nearest Port: Taizhou
Annual Revenue: US$50 Million - US$100 Million
Total Revenue: US$50 Million - US$100 Million
Export Revenue: Below US$1 Million
Annual Output: confidential
Registered Capital: US$10 Million - US$50 Million
Export Percentage: 11% - 20%
Payment Modes: USD, JPY, CNY
Lead Time: 31 days
Import/Export Mode: Have Own Export License